We manage and develop intellectual property strategies for innovations resulting from research and development activities in the life sciences, especially biotechnology, with particular experience in the drafting, filing and prosecution of patent applications related to nucleotide and protein sequences (e.g. miRNA), cell lines (e.g. stem cells, iPSs), antibodies, microorganisms, animal models, gene therapies and genetic engineering of plants and plant varieties.